CENPA and neoplasm: Downregulation of cyclin A2 (Ccna2), Polo-like kinase 1 (Plk1) and the centromer protein A (Cenpa) which are typically upregulated in tumour cells to foster cell cycle and mitosis agree well with the observed cell cycle arrest and demonstrate the therapeutic effect of these experimental inhibitors.